| 2025-05-01 | -24.0% | earnings | Seeking Alpha | Select Medical GAAP EPS of $0.44 misses by $0.02, revenue of $1.35B misses by $50M |
| 2025-05-01 | -24.0% | news | Seeking Alpha | Select Medical declares $0.0625 dividend |
| 2025-05-01 | -24.0% | legal | SEC EDGAR | SEM 8-K: 2.02, 8.01 (SEC Filing) |
| 2025-08-01 | -18.9% | earnings | Seeking Alpha | Select Medical reaffirms $5.3B–$5.5B 2025 revenue outlook as inpatient rehab expansion accelerates |
| 2025-08-01 | -18.9% | earnings | Seeking Alpha | Select Medical Holdings Corporation (SEM) Q2 2025 Earnings Call Transcript |
| 2022-01-18 | -14.2% | legal | SEC EDGAR | SEM 8-K: 2.02 and (SEC Filing) |
| 2025-07-31 | -11.2% | news | Seeking Alpha | Select Medical declares $0.0625 dividend |
| 2025-07-31 | -11.2% | earnings | Seeking Alpha | Select Medical GAAP EPS of $0.32 beats by $0.07, revenue of $1.34B misses by $10M |
| 2025-07-31 | -11.2% | legal | SEC EDGAR | SEM 8-K: 2.02, 8.01 (SEC Filing) |
| 2024-10-31 | +11.0% | legal | SEC EDGAR | SEM 8-K: 2.02, 8.01 (SEC Filing) |
| 2024-08-01 | -10.8% | legal | SEC EDGAR | SEM 8-K: 5.02 (SEC Filing) |
| 2024-08-01 | -10.8% | legal | SEC EDGAR | SEM 8-K: 2.02, 8.01 (SEC Filing) |
| 2024-08-01 | -10.8% | legal | SEC EDGAR | SEM 8-K: 1.01, 2.03 (SEC Filing) |
| 2024-05-02 | +10.1% | legal | SEC EDGAR | SEM 8-K: 2.02, 8.01 (SEC Filing) |
| 2026-03-03 | +8.5% | M&A | Seeking Alpha | Select Medical jumps as consortium strikes $3.9B cash buyout at $16.50 per share |
| 2026-03-03 | +8.5% | legal | SEC EDGAR | SEM 8-K: 1.01, 7.01 (SEC Filing) |
| 2026-03-03 | +8.5% | legal | PR Newswire | SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Select Medical Holdings Corporation (NYSE: SEM) - PR Newswire |
| 2026-02-19 | -8.5% | earnings | Seeking Alpha | Select Medical Non-GAAP EPS of $0.16 misses by $0.07, revenue of $1.4B beats by $40M |
| 2026-02-19 | -8.5% | legal | SEC EDGAR | SEM 8-K: 2.02, 8.01 (SEC Filing) |
| 2026-02-19 | -8.5% | news | Yahoo Finance | Select Medical Holdings Corporation Announces Results For Its Fourth Quarter and Year Ended December 31, 2025, Its 2026 Business Outlook, and Cash Dividend - Yahoo Finance |
| 2025-11-25 | +8.4% | news | Seeking Alpha | Select Medical co-founder proposes to buy all shares, take company private |
| 2026-02-20 | -7.8% | earnings | Seeking Alpha | Select Medical anticipates up to $5.8B revenue in 2026 while advancing inpatient rehab expansion |
| 2026-02-20 | -7.8% | earnings | Seeking Alpha | Select Medical Holdings Corporation (SEM) Q4 2025 Earnings Call Transcript |
| 2026-02-20 | -7.8% | news | Seeking Alpha | Select Medical declares $0.0625 dividend |
| 2023-02-23 | -7.3% | legal | SEC EDGAR | SEM 8-K: 2.02, 8.01 (SEC Filing) |
| 2022-11-03 | -7.0% | legal | SEC EDGAR | SEM 8-K: 2.02, 8.01 (SEC Filing) |
| 2023-07-19 | +6.5% | legal | SEC EDGAR | SEM 8-K: 2.02 and (SEC Filing) |
| 2025-02-20 | -6.0% | news | Seeking Alpha | Select Medical declares $0.0625 dividend |
| 2025-02-20 | -6.0% | earnings | Seeking Alpha | Select Medical Non-GAAP EPS of $0.18 misses by $0.06, revenue of $1.22B misses by $280M |
| 2025-02-20 | -6.0% | legal | SEC EDGAR | SEM 8-K: 2.02, 8.01 (SEC Filing) |
| 2025-10-31 | -6.0% | earnings | Seeking Alpha | Select Medical outlines $5.3B–$5.5B 2025 revenue target as CMS rule deferral boosts Q3 results |
| 2025-10-31 | -6.0% | earnings | Seeking Alpha | Select Medical Holdings Corporation (SEM) Q3 2025 Earnings Call Transcript |
| 2022-05-05 | +5.0% | legal | SEC EDGAR | SEM 8-K: 2.02, 8.01 (SEC Filing) |
| 2024-11-20 | +5.0% | news | Seeking Alpha | Flex set to join S&P midcap 400; Azenta and Concentra Group to join S&P smallcap 600 |
| 2023-09-01 | -4.8% | legal | SEC EDGAR | SEM 8-K: 1.01 and (SEC Filing) |
| 2024-11-12 | -4.7% | news | Forbes | Select Medical To Spin-Off Concentra On November 25th - Forbes |
| 2024-02-22 | +4.6% | legal | SEC EDGAR | SEM 8-K: 2.02, 8.01 (SEC Filing) |
| 2025-10-08 | +4.3% | news | Seeking Alpha | Select Medical jumps 14% to record best intraday gain in years |
| 2021-08-05 | -4.1% | legal | SEC EDGAR | SEM 8-K: 2.02, 5.02 (SEC Filing) |
| 2025-05-03 | +4.1% | earnings | Seeking Alpha | Select Medical targets $5.3B-$5.5B revenue range for 2025 as inpatient rehab expands |
| 2025-05-03 | +4.1% | earnings | Seeking Alpha | Select Medical Holdings Corporation (SEM) Q1 2025 Earnings Call Transcript |
| 2021-05-06 | -4.1% | legal | SEC EDGAR | SEM 8-K: 2.02, 8.01 (SEC Filing) |
| 2023-11-02 | -4.0% | legal | SEC EDGAR | SEM 8-K: 2.02, 8.01 (SEC Filing) |
| 2022-08-04 | -3.8% | legal | SEC EDGAR | SEM 8-K: 2.02, 8.01 (SEC Filing) |
| 2022-08-04 | -3.8% | legal | SEC EDGAR | SEM 8-K: 5.02 (SEC Filing) |
| 2024-06-27 | +3.8% | legal | SEC EDGAR | SEM 8-K: 1.01, 7.01 (SEC Filing) |
| 2023-05-04 | +3.7% | legal | SEC EDGAR | SEM 8-K: 2.02, 8.01 (SEC Filing) |
| 2024-11-19 | +3.7% | news | Seeking Alpha | Select Medical prices $550M senior notes |
| 2024-11-19 | +3.7% | legal | SEC EDGAR | SEM 8-K: 1.01, 8.01 (SEC Filing) |
| 2024-11-19 | +3.7% | legal | SEC EDGAR | SEM 8-K: 8.01 and (SEC Filing) |
| 2023-08-02 | +3.4% | legal | SEC EDGAR | SEM 8-K: 5.02 (SEC Filing) |
| 2023-08-01 | +2.8% | legal | SEC EDGAR | SEM 8-K: 1.01 and (SEC Filing) |
| 2025-02-28 | -2.8% | news | Seeking Alpha | Hospital stocks fall amid Medicaid funding concerns |
| 2022-02-24 | -2.7% | legal | SEC EDGAR | SEM 8-K: 2.02 and (SEC Filing) |
| 2023-09-07 | -2.7% | legal | SEC EDGAR | SEM 8-K: 5.02, 7.01 (SEC Filing) |
| 2024-11-26 | -2.6% | legal | SEC EDGAR | SEM 8-K: 2.01 and (SEC Filing) |
| 2023-06-06 | +2.5% | legal | SEC EDGAR | SEM 8-K: 1.01 and (SEC Filing) |
| 2025-10-30 | -2.4% | earnings | Seeking Alpha | Select Medical Non-GAAP EPS of $0.23 beats by $0.08, revenue of $1.36B beats by $30M |
| 2025-10-30 | -2.4% | news | Seeking Alpha | Select Medical declares $0.0625 dividend |
| 2025-10-30 | -2.4% | legal | SEC EDGAR | SEM 8-K: 2.02, 8.01 (SEC Filing) |
| 2025-12-19 | -2.2% | legal | SEC EDGAR | SEM 8-K: 5.02 and (SEC Filing) |
| 2023-03-01 | -2.1% | legal | SEC EDGAR | SEM 8-K: 5.02 and (SEC Filing) |
| 2026-04-14 | -2.1% | news | Simply Wall St. | European Growth Stocks Insiders Are Eager To Own |
| 2026-02-18 | -2.1% | earnings | Seeking Alpha | Select Medical Q4 2025 Earnings Preview |
| 2024-11-18 | -2.0% | expansion | Seeking Alpha | Select Medical subsidiary launches $850M debt offering |
| 2024-11-18 | -2.0% | legal | SEC EDGAR | SEM 8-K: 7.01, 8.01 (SEC Filing) |
| 2025-07-18 | -1.9% | legal | Seeking Alpha | Select Medical: Despite A Change In The Regulatory Environment, This Prospect Is Worth Considering |
| 2021-11-04 | +1.5% | legal | SEC EDGAR | SEM 8-K: 2.02 and (SEC Filing) |
| 2026-04-16 | -1.4% | news | StockStory | 1 Value Stock on Our Watchlist and 2 Facing Headwinds |
| 2026-03-25 | +1.4% | earnings | StockStory | Reflecting On Outpatient & Specialty Care Stocks’ Q4 Earnings: Select Medical (NYSE:SEM) |
| 2026-03-25 | +1.4% | news | Simply Wall St. | European Stocks That May Be Priced Below Their Estimated Value |
| 2024-11-07 | +1.2% | legal | SEC EDGAR | SEM 8-K: 8.01 and (SEC Filing) |
| 2021-11-02 | +1.2% | legal | SEC EDGAR | SEM 8-K: 5.02, 7.01 (SEC Filing) |
| 2024-07-17 | +1.1% | legal | SEC EDGAR | SEM 8-K: 1.01, 2.03 (SEC Filing) |
| 2024-12-04 | -1.0% | legal | SEC EDGAR | SEM 8-K: 1.01, 2.03, 8.01 (SEC Filing) |
| 2023-02-22 | +1.0% | legal | SEC EDGAR | SEM 8-K: 1.01 and (SEC Filing) |
| 2024-04-26 | +0.9% | legal | SEC EDGAR | SEM 8-K: 5.02, 5.03, 5.07 (SEC Filing) |
| 2024-07-12 | +0.8% | legal | SEC EDGAR | SEM 8-K: 2.02 and (SEC Filing) |
| 2025-02-21 | -0.6% | earnings | Seeking Alpha | Select Medical Holdings Corporation (SEM) Q4 2024 Earnings Call Transcript |
| 2023-08-03 | -0.6% | legal | SEC EDGAR | SEM 8-K: 2.02, 8.01 (SEC Filing) |
| 2026-04-22 | -0.6% | earnings | Cổng thông tin điện tử Tỉnh Sơn La | SEM (Select Medical Holdings Corporation) posts steep Q4 2025 EPS miss, sees nearly flat stock movement in trading today. - Graham Number - Cổng thông tin điện tử Tỉnh Sơn La |
| 2021-12-28 | +0.5% | legal | SEC EDGAR | SEM 8-K: 1.01 and (SEC Filing) |
| 2025-09-02 | -0.5% | executive | Seeking Alpha | Select Medical names new CEO, announces executive leadership changes |
| 2025-09-02 | -0.5% | legal | SEC EDGAR | SEM 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-04-09 | -0.4% | news | PR Newswire | Select Medical Holdings Corporation to Announce First Quarter 2026 Results on Thursday, April 30, 2026 |
| 2021-06-04 | +0.3% | legal | SEC EDGAR | SEM 8-K: 1.01 and (SEC Filing) |
| 2026-04-23 | -0.3% | news | StockStory | 3 Reasons to Sell SEM and 1 Stock to Buy Instead |
| 2026-04-23 | -0.3% | analyst | Seeking Alpha | Select Medical Holdings Corporation (SEM) Shareholder/Analyst Call Prepared Remarks Transcript |
| 2026-04-21 | -0.2% | news | StockStory | 2 Cash-Producing Stocks with Solid Fundamentals and 1 We Question |
| 2026-04-02 | -0.0% | news | StockStory | 1 Stock Under $50 to Target This Week and 2 We Ignore |
| 2025-04-29 | -0.0% | legal | SEC EDGAR | SEM 8-K: 5.02, 5.03, 5.07 (SEC Filing) |
| 2026-04-26 | — | news | Simply Wall St. | Just Three Days Till 7-Eleven Malaysia Holdings Berhad (KLSE:SEM) Will Be Trading Ex-Dividend |
| 2026-04-24 | — | news | Insider Monkey | Is Select Medical Holdings Corporation (SEM) A Good Stock To Buy Now? |